Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Stephan A. Grupp, Michael A. Pulsipher, Jochen Buechner et al.|Blood|2016

Cited by 83